Week In Review: China's I-Mab Stages $104 Million Nasdaq IPO
January 18, 2020 at 14:34 PM EST
I-Mab, a Shanghai biotech, raised $104 million in its IPO on the Nasdaq exchange to support its portfolio of biologic products.The offering was priced at $14 per ADS but the price has moved 10% lower to $12.58 in initial trading.
